List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors | No observations |
PAHO Strategic Fund Medicine List | 2.6.4.1. Medicines for Hepatitis B | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors | No observations |
PAHO Strategic Fund Medicine List | 2.6.4.1. Medicines for Hepatitis B | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors | No observations |
PAHO Strategic Fund Medicine List | 2.6.4.1. Medicines for Hepatitis B | No observations |